Betamethasone Dipropionate Lotion
Loading...Betamethasone Dipropionate Lotion Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Betamethasone Dipropionate Lotion USP, 0.05% is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older.
History
There is currently no drug history available for this drug.
Other Information
Betamethasone Dipropionate Lotion USP, 0.05% contains betamethasone dipropionate, USP, a synthetic adrenocorticosteroid, for dermatologic use. Betamethasone, an analog of prednisolone, has high corticosteroid activity and slight mineralocorticoid activity. Betamethasone dipropionate is the 17, 21-dipropionate ester of betamethasone.
Chemically, betamethasone dipropionate is 9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, with the empirical formula C28H37FO7, a molecular weight of 504.6, and the following structural formula:
Betamethasone dipropionate is a white to creamy white, odorless crystalline powder, insoluble in water.
Each gram of Betamethasone Dipropionate Lotion USP, 0.05% contains 0.64 mg betamethasone dipropionate (equivalent to 0.5 mg betamethasone) in a lotion base of carbomer homopolymer type B, isopropyl alcohol, and purified water. Sodium hydroxide is used to adjust pH.
Sources
Betamethasone Dipropionate Lotion Manufacturers
-
A-s Medication Solutions Llc
![Betamethasone Dipropionate Lotion [A-s Medication Solutions Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Betamethasone Dipropionate Lotion | A-s Medication Solutions Llc
Apply a few drops of Betamethasone Dipropionate Lotion USP, 0.05% to the affected area and massage lightly until it disappears. Apply twice daily, in the morning and at night.
Betamethasone Dipropionate Lotion USP, 0.05% is not to be used with occlusive dressings.
-
Perrigo New York Inc
Betamethasone Dipropionate Lotion | Perrigo New York Inc
Apply a few drops of Betamethasone Dipropionate Lotion USP, 0.05% to the affected area and massage lightly until it disappears. Apply twice daily, in the morning and at night.
Betamethasone Dipropionate Lotion USP, 0.05% is not to be used with occlusive dressings.
-
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Betamethasone Dipropionate Lotion | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Apply a few drops of betamethasone dipropionate lotion USP (augmented), 0.05% to the affected skin areas once or twice daily and massage lightly until the lotion disappears.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Betamethasone dipropionate lotion USP (augmented), 0.05% is a super-high-potency topical corticosteroid. Treatment with betamethasone dipropionate lotion USP (augmented), 0.05% should be limited to 2 consecutive weeks and amounts should not exceed 50 mL per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Betamethasone dipropionate lotion USP (augmented), 0.05% should not be used with occlusive dressings unless directed by a physician.
Betamethasone dipropionate lotion USP (augmented), 0.05% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
-
Taro Pharmaceuticals U.s.a., Inc.
Betamethasone Dipropionate Lotion | Taro Pharmaceuticals U.s.a., Inc.
Apply a few drops of betamethasone dipropionate lotion (augmented) to the affected skin areas once or twice daily and massage lightly until the lotion disappears.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Betamethasone dipropionate lotion (augmented) is a super-high-potency topical corticosteroid. Treatment with betamethasone dipropionate lotion (augmented) should be limited to 2 consecutive weeks and amounts should not exceed 50 mL per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Betamethasone dipropionate lotion (augmented) should not be used with occlusive dressings unless directed by a physician.
Betamethasone dipropionate lotion (augmented) is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
![Betamethasone Dipropionate Lotion [Perrigo New York Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e6018480-7788-472d-a2d1-ccccffcd258e&name=0e059e98-cddf-4c2f-abaa-c9bc86863745-03.jpg)
![Betamethasone Dipropionate Lotion, Augmented [E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.]](https://www.recallguide.org/wp-content/themes/bootstrap/assets/img/drug-image-placeholder.jpg)
Login To Your Free Account